Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D., from the Mayo Clinic in ...
New research highlights the effectiveness of ubrogepant in treating migraines during the prodrome phase. The study was published in Neurology. Migraines are common headache disorders that affect an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results